The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Clinical Manifestations, Diagnosis, and Treatment of Sarcoidosis
Open accessAbstract
The focus of this review is current knowledge about the epidemiology, clinical manifestations, diagnosis, and treatment of both pulmonary sarcoidosis and extrapulmonary sarcoidosis. Although intrathoracic involvement is the hallmark of the disease, present in over 90% of patients, sarcoidosis can affect virtually any organ. Clinical presentations of sarcoidosis are diverse, ranging from asymptomatic, incidental findings to organ failure. Diagnosis requires the presence of noncaseating granuloma and compatible presentations after exclusion of other identifiable causes. Spontaneous remission is frequent, so treatment is not always indicated unless the disease is symptomatic or causes progressive organ damage/dysfunction. Glucocorticoids are the cornerstone of treatment of sarcoidosis even though evidence from randomized controlled studies is lacking. Glucocorticoid-sparing agents and biologic agents are often used as second- and third-line therapy for patients who do not respond to glucocorticoids or experience serious adverse effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical Characteristics of Patients in a Case Control Study of Sarcoidosis
BAUGHMAN, R. P., TEIRSTEIN, A. S., JUDSON, M. A., ROSSMAN, M. D., YEAGER, H., BRESNITZ, E. A., DePALO, L., HUNNINGHAKE, G., IANNUZZI, M. C., JOHNS, C. J., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.10.2104046 · Cited by 1,808
Birnie, D. H., Sauer, W. H., Bogun, F., Cooper, J. M., Culver, D. A., Duvernoy, C. S., Judson, M. A., Kron, J., Mehta, D., Cosedis Nielsen, J., et al. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.03.043 · Cited by 1,479
Hunninghake, G. W., Costabel, U., Ando, M., Baughman, R. P., Cordier, J. F., du Bois, R. M., Eklúnd, A., Kitaichi, M., Lynch, J. P., Rizzato, G., et al. (1999) · PubMed · Cited by 1,324
Racial Differences in Sarcoidosis Incidence: A 5-Year Study in a Health Maintenance Organization
Rybicki, B. A., Major, M., Popovich, J., Maliank, M. J., & lannuzzi, M. C. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009096 · Cited by 1,011
Spagnolo, P., Rossi, G., Trisolini, R., Sverzellati, N., Baughman, R. P., & Wells, A. U. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30064-x · Cited by 949
Elevation of serum angiotension-converting-enzyme (ACE) level in sarcoidosis
Lieberman, J. (1975) · The American Journal of Medicine · doi:10.1016/0002-9343(75)90395-2 · Cited by 870
Interstitial lung disease guideline
Wells, A. U., Hirani, N., & on behalf of the BTS Interstitial Lung Disease Guideline Group, A. S. O. T. B. T. S. S. O. C. C. (2008) · Thorax · doi:10.1136/thx.2008.101691 · Cited by 866
ATS/ERS/WASOG statement on sarcoidosis
Costabel, U., Hunninghake, G. W., & on behalf of the Sarcoidosis Statement Committee (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.14d02.x · Cited by 862
Central nervous system sarcoidosisdiagnosis and management
Zajicek, J. P. (1999) · QJM · doi:10.1093/qjmed/92.2.103 · Cited by 742
Infliximab Therapy in Patients with Chronic Sarcoidosis and Pulmonary Involvement
Baughman, R. P., Drent, M., Kavuru, M., Judson, M. A., Costabel, U., du Bois, R., Albera, C., Brutsche, M., Davis, G., Donohue, J. F., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200603-402oc · Cited by 714
LONGCOPE, W. T., & PREIMAN, D. G. (1952) · Medicine · doi:10.1097/00005792-195202000-00001 · Cited by 710
Cardiac Sarcoidosis: Epidemiology, Characteristics, and Outcome Over 25 Years in a Nationwide Study
Kandolin, R., Lehtonen, J., Airaksinen, J., Vihinen, T., Miettinen, H., Ylitalo, K., Kaikkonen, K., Tuohinen, S., Haataja, P., Kerola, T., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.011522 · Cited by 582
Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK
Gribbin, J., Hubbard, R. B., Le Jeune, I., Smith, C. J. P., West, J., & Tata, L. J. (2006) · Thorax · doi:10.1136/thx.2006.062836 · Cited by 576
Birnie, D. H., Nery, P. B., Ha, A. C., & Beanlands, R. S. B. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.605 · Cited by 569
Herbort, C. P., Rao, N. A., Mochizuki, M., & Commi, T. M. O. T. S. (2009) · Ocular Immunology and Inflammation · doi:10.1080/09273940902818861 · Cited by 542
A Concise Review of Pulmonary Sarcoidosis
Baughman, R. P., Culver, D. A., & Judson, M. A. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201006-0865ci · Cited by 536
Histologic diagnostic rate of cardiac sarcoidosis: Evaluation of endomyocardial biopsies
Uemura, A., Morimoto, S.-I., Hiramitsu, S., Kato, Y., Ito, T., & Hishida, H. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70115-8 · Cited by 487
Epidemiology of sarcoidosis in Japan
Morimoto, T., Azuma, A., Abe, S., Usuki, J., Kudoh, S., Sugisaki, K., Oritsu, M., & Nukiwa, T. (2008) · European Respiratory Journal · doi:10.1183/09031936.00075307 · Cited by 429
Sarcoidosis: A Clinicopathologic Review of Three Hundred Cases, Including Twenty-Two Autopsies
Ricker, W., & Clark, M. (1949) · American Journal of Clinical Pathology · doi:10.1093/ajcp/19.8.725 · Cited by 423
Sarcoidosis in America. Analysis Based on Health Care Use
Baughman, R. P., Field, S., Costabel, U., Crystal, R. G., Culver, D. A., Drent, M., Judson, M. A., & Wolff, G. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201511-760oc · Cited by 421
Etanercept for the Treatment of Stage II and III Progressive Pulmonary Sarcoidosis
Utz, J. P., Limper, A. H., Kalra, S., Specks, U., Scott, J. P., Vuk-Pavlovic, Z., & Schroeder, D. R. (2003) · Chest · doi:10.1378/chest.124.1.177 · Cited by 390
Sarcoidosis: epidemiology and prognosis. A 15-year European study.
Hillerdal, G., Nõu, E., Osterman, K., & Schmekel, B. (1984) · PubMed · doi:10.1164/arrd.1984.130.1.29 · Cited by 368
Judson, M. A., Boan, A. D., & Lackland, D. T. (2012) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 351
Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial.
Baughman, R. P., Winget, D., & Lower, E. E. (2000) · PubMed · Cited by 344
Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial
Judson, M. A., Baughman, R. P., Costabel, U., Flavin, S., Lo, K. H., Kavuru, M. S., Drent, M., & the Centocor T48 Sarcoidosis investigators (2008) · European Respiratory Journal · doi:10.1183/09031936.00051907 · Cited by 324
Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden
Arkema, E. V., Grunewald, J., Kullberg, S., Eklund, A., & Askling, J. (2016) · European Respiratory Journal · doi:10.1183/13993003.00477-2016 · Cited by 316
Epidemiology of Sarcoidosis 1946-2013
Ungprasert, P., Carmona, E. M., Utz, J. P., Ryu, J. H., Crowson, C. S., & Matteson, E. L. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.10.024 · Cited by 300
Self-citationHypercalcemia in granulomatous disorders: a clinical review
Sharma, O. P. (2000) · Current Opinion in Pulmonary Medicine · doi:10.1097/00063198-200009000-00010 · Cited by 295
Chiu, C.-Z., Nakatani, S., Zhang, G., Tachibana, T., Ohmori, F., Yamagishi, M., Kitakaze, M., Tomoike, H., & Miyatake, K. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.08.083 · Cited by 289
Hepatic Sarcoidosis: Clinicopathologic Features in 100 Patients
Devaney, K., Goodman, Z. D., Epstein, M. S., Zimmerman, H. J., & Ishak, K. G. (1993) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199312000-00009 · Cited by 287
Löfgren’s syndrome revisited: a study of 186 patients
Mañá, J., Gómez-Vaquero, C., Montero, A., Salazar, A., Marcoval, J., Valverde, J., Manresa, F., & Pujol, R. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00223-5 · Cited by 272
Pasadhika, S., & Rosenbaum, J. T. (2015) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2015.08.009 · Cited by 267
Gastrointestinal and Hepatic Manifestations of Sarcoidosis
Ebert, E. C., Kierson, M., & Hagspiel, K. D. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02202.x · Cited by 266
Cardiac Sarcoidosis: A Retrospective Study of 41 Cases
Chapelon-Abric, C., de Zuttere, D., Duhaut, P., Veyssier, P., Wechsler, B., Huong, D. L. T., de Gennes, C., Papo, T., Blétry, O., Godeau, P., et al. (2004) · Medicine · doi:10.1097/01.md.0000145367.17934.75 · Cited by 261
Corticosteroid Therapy for Cardiac Sarcoidosis: A Systematic Review
Sadek, M. M., Yung, D., Birnie, D. H., Beanlands, R. S., & Nery, P. B. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.02.004 · Cited by 258
Chareonthaitawee, P., Beanlands, R. S., Chen, W., Dorbala, S., Miller, E. J., Murthy, V. L., Birnie, D. H., Chen, E. S., Cooper, L. T., Tung, R. H., et al. (2017) · Journal of Nuclear Cardiology · doi:10.1007/s12350-017-0978-9 · Cited by 254
Methotrexate therapy for chronic noninfectious uveitis
Samson, C. M., Waheed, N., Baltatzis, S., & Foster, C. S. (2001) · Ophthalmology · doi:10.1016/s0161-6420(01)00576-0 · Cited by 250
Neurosarcoidosis: a study of 30 new cases
Joseph, F. G., & Scolding, N. J. (2009) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.151977 · Cited by 248
Sarcoidosis: A comprehensive review and update for the dermatologist
Haimovic, A., Sanchez, M., Judson, M. A., & Prystowsky, S. (2012) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.11.965 · Cited by 237
von Bartheld, M. B., Dekkers, O. M., Szlubowski, A., Eberhardt, R., Herth, F. J., in ‘t Veen, J. C. C. M., de Jong, Y. P., van der Heijden, E. H. F. M., Tournoy, K. G., Claussen, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.5823 · Cited by 233
Renal Sarcoidosis: Clinical, Laboratory, and Histologic Presentation and Outcome in 47 Patients
Mahévas, M., Lescure, F. X., Boffa, J.-J., Delastour, V., Belenfant, X., Chapelon, C., Cordonnier, C., Makdassi, R., Piette, J.-C., Naccache, J.-M., et al. (2009) · Medicine · doi:10.1097/md.0b013e31819de50f · Cited by 224
Thomas, K. W. (2003) · JAMA · doi:10.1001/jama.289.24.3300 · Cited by 220
Pharmacotherapy for pulmonary sarcoidosis: A delphi consensus study
Schutt, A. C., Bullington, W. M., & Judson, M. A. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2009.12.009 · Cited by 206
Diagnostic Utility of Angiotensin-Converting Enzyme in Sarcoidosis: A Population-Based Study
Ungprasert, P., Carmona, E. M., Crowson, C. S., & Matteson, E. L. (2016) · Lung · doi:10.1007/s00408-015-9826-3 · Cited by 197
Self-citationBaughman, R. P., Judson, M. A., Costabel, U., duBois, R. M., Drent, M., Kavuru, M., Lo, K. H., Andresen, C., Schlenker-Herceg, R., & Barnathan, E. S. (2005) · Chest · doi:10.1378/chest.128.2.1062 · Cited by 194
Sarcoidosis—scientific progress and clinical challenges
Chen, E. S., & Moller, D. R. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.93 · Cited by 194
Sarcoidosis in Black Women in the United States
Cozier, Y. C., Berman, J. S., Palmer, J. R., Boggs, D. A., Serlin, D. M., & Rosenberg, L. (2011) · Chest · doi:10.1378/chest.10-0413 · Cited by 182
Sarcoidosis: The Nephrologist’s Perspective
Berliner, A. R., Haas, M., & Choi, M. J. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.07.022 · Cited by 181
Judson, M. A. (2008) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2008.03.009 · Cited by 177
Moller, D. R. (1997) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(05)70413-5 · Cited by 170
Chen, E. S., & Möller, D. R. (2008) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2008.03.011 · Cited by 168
Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis
Vorselaars, A. D. M., Crommelin, H. A., Deneer, V. H. M., Meek, B., Claessen, A. M. E., Keijsers, R. G. M., van Moorsel, C. H. M., & Grutters, J. C. (2015) · European Respiratory Journal · doi:10.1183/09031936.00227014 · Cited by 161
Endobronchial Biopsy for Sarcoidosis
Shorr, A. F., Torrington, K. G., & Hnatiuk, O. W. (2001) · Chest · doi:10.1378/chest.120.1.109 · Cited by 159
Tavee, J. O., Karwa, K., Ahmed, Z., Thompson, N., Parambil, J., & Culver, D. A. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.03.011 · Cited by 159
Airway Involvement in Sarcoidosis
Polychronopoulos, V. S., & Prakash, U. B. S. (2009) · CHEST Journal · doi:10.1378/chest.08-2569 · Cited by 158
Sarcoid arthritis: clinical characteristics, diagnostic aspects, and risk factors
VISSER, H. K. A., Vos, K., Zanelli, E., Verduyn, W., Schreuder, G. M. T., Speyer, I., Breedveld, F. C., & Hazes, J. M. W. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.6.499 · Cited by 154
Etanercept for Refractory Ocular Sarcoidosis
Baughman, R. P., Lower, E. E., Bradley, D., Raymond, L. A., & Kaufman, A. H. (2005) · CHEST Journal · doi:10.1016/s0012-3692(15)50471-6 · Cited by 145
Abdominal CT findings in sarcoidosis: radiologic and clinical correlation.
Warshauer, D. M., Dumbleton, S. A., Molina, P. L., Yankaskas, B. C., Parker, L. A., & Woosley, J. T. (1994) · Radiology · doi:10.1148/radiology.192.1.8208972 · Cited by 143
Evans, M., Sharma, O. P., LABREE, L. D., Smith, R. E., & Rao, N. A. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.05.074 · Cited by 142
Management of Cardiac Sarcoidosis in the United States
Hamzeh, N. Y., Wamboldt, F. S., & Weinberger, H. D. (2011) · CHEST Journal · doi:10.1378/chest.11-0263 · Cited by 135
Neurosarcoidosis: Clinical manifestations, diagnosis and treatment
Nozaki, K., & Judson, M. A. (2012) · La Presse Médicale · doi:10.1016/j.lpm.2011.12.017 · Cited by 124
Nagai, S., Yokomatsu, T., Tanizawa, K., Ikezoe, K., Handa, T., Ito, Y., Ogino, S., & Izumi, T. (2014) · Internal Medicine · doi:10.2169/internalmedicine.53.0794 · Cited by 122
Baughman, R. P., & Lower, E. E. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8492-9 · Cited by 121
Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis.
Sweiss, N., Noth, I., Mirsaeidi, M. S., Zhang, W., Naureckas, E. T., Hogarth, D. K., Strek, M. E., Caligiuri, P., Machado, R. F., Niewold, T. B., et al. (2014) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 119
Sarcoidosis: A comprehensive review and update for the dermatologist
Haimovic, A., Sanchez, M., Judson, M. A., & Prystowsky, S. D. (2012) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2012.02.003 · Cited by 118
Long-term outcomes of refractory neurosarcoidosis treated with infliximab
Aubart, F. C., Bouvry, D., Galanaud, D., Dehais, C., Mathey, G., Psimaras, D., Haroche, J., Pottier, C., Hie, M., Mathian, A., et al. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8444-9 · Cited by 115
Pathophysiology and clinical management of cardiac sarcoidosis
Hamzeh, N. Y., Steckman, D. A., Sauer, W. H., & Judson, M. A. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.22 · Cited by 113
A prospective study of 32 patients with neurosarcoidosis.
Allen, R. K. A., Sellars, R. E., & Sandstrom, P. A. (2003) · PubMed · Cited by 106
Smoking, obesity and risk of sarcoidosis: A population-based nested case-control study
Ungprasert, P., Crowson, C. S., & Matteson, E. L. (2016) · Respiratory Medicine · doi:10.1016/j.rmed.2016.10.003 · Cited by 106
Self-citationGlucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatica
Kremers, H. M., Reinalda, M. S., Crowson, C. S., Davis, J. M., Hunder, G. G., & Gabriel, S. E. (2007) · Arthritis Care & Research · doi:10.1002/art.22548 · Cited by 105
Treatment of neurosarcoidosis: A comparative study of methotrexate and mycophenolate mofetil
Bitoun, S., Bouvry, D., Borie, R., Mahévas, M., Sacré, K., Haroche, J., Psimaras, D., Pottier, C., Mathian, A., Hie, M., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003431 · Cited by 105
Clinical Characteristics and Outcome of Hepatic Sarcoidosis: A Population-Based Study 1976–2013
Ungprasert, P., Crowson, C. S., Simonetto, D. A., & Matteson, E. L. (2017) · The American Journal of Gastroenterology · doi:10.1038/ajg.2017.231 · Cited by 104
Self-citationGovender, P., & Berman, J. S. (2015) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2015.08.003 · Cited by 93
Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab
Crommelin, H. A., van der Burg, L. M., Vorselaars, A. D. M., Drent, M., van Moorsel, C. H. M., Rijkers, G. T., Deneer, V. H. M., & Grutters, J. C. (2016) · Respiratory Medicine · doi:10.1016/j.rmed.2016.04.011 · Cited by 91
The treatment of pulmonary sarcoidosis
Judson, M. A. (2012) · Respiratory Medicine · doi:10.1016/j.rmed.2012.01.013 · Cited by 79
Clinical Implications of Seizures in Neurosarcoidosis
Krumholz, A., Stern, B. J., & Stern, E. G. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530200084023 · Cited by 76
Clinical Characteristics of Ocular Sarcoidosis: A Population-Based Study 1976–2013
Ungprasert, P., Tooley, A. A., Crowson, C. S., Matteson, E. L., & Smith, W. M. (2017) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2017.1386791 · Cited by 71
Self-citationLong-term visual and systemic prognoses of 83 cases of biopsy-proven sarcoid uveitis
Rochepeau, C., Jamilloux, Y., Kerever, S., Febvay, C., Pérard, L., Broussolle, C., Burillon, C., Kodjikian, L., & Sève, P. (2016) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2016-309767 · Cited by 66
A retrospective pilot study examining the use of Acthar gel in sarcoidosis patients
Baughman, R. P., Barney, J. B., O’Hare, L., et al. (2015) · Respiratory Medicine · doi:10.1016/j.rmed.2015.11.007 · Cited by 65
Baughman, R. P., Judson, M. A., Lower, E. E., Drent, M., Costabel, U., Flavin, S. K., Lo, K. H., & Barnathan, E. S. (2016) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 63
Park, J. E., Kim, Y. S., Kang, M. J., Kim, C. J., Han, C. H., Lee, S. M., & Park, S. C. (2018) · Respiratory Medicine · doi:10.1016/j.rmed.2018.03.028 · Cited by 62
Sarcoidosis: Epidemiology and Prognosis
Hillerdal, G., Nõu, E., Österman, K., & Schmekel, B. (2015) · American Review of Respiratory Disease · Cited by 60
Ungprasert, P., Wetter, D. A., Crowson, C. S., & Matteson, E. L. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13760 · Cited by 60
Self-citationEfficacy and Tolerance of Anti–Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis
Heidelberger, V., Oro, S., Marquet, A., et al. (2017) · JAMA Dermatology · doi:10.1001/jamadermatol.2017.1162 · Cited by 56
Causes of death in patients with chronic sarcoidosis.
Hu, X., Carmona, E. M., Yi, E. S., Pellikka, P. A., & Ryu, J. H. (2016) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 50
Self-citationOcular Involvement in Sarcoidosis
Rothová, A., & Groen, F. (2017) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0037-1602382 · Cited by 43
A Comprehensive Review of Hepatic Sarcoid
Deutsch‐Link, S., Fortuna, D., & Weinberg, E. M. (2018) · Seminars in Liver Disease · doi:10.1055/s-0038-1666853 · Cited by 43
Judson, M. A. (2019) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000596 · Cited by 43
Clinical Characteristics of Sarcoid Arthropathy: A Population‐Based Study
Ungprasert, P., Crowson, C. S., & Matteson, E. L. (2015) · Arthritis Care & Research · doi:10.1002/acr.22737 · Cited by 41
Self-citationCharacteristics and Long-Term Outcome of Neurosarcoidosis: A Population-Based Study from 1976-2013
Ungprasert, P., Crowson, C. S., & Matteson, E. L. (2017) · Neuroepidemiology · doi:10.1159/000477300 · Cited by 31
Self-citationHepatic sarcoidosis: a case series
Ennaifer, R., Ayadi, S., Romdhane, H., Cheikh, M., Nejma, H. B., Bougassas, W., & Hadj, N. B. (2016) · Pan African Medical Journal · doi:10.11604/pamj.2016.24.209.7980 · Cited by 16
Outcome of pulmonary sarcoidosis: a population-based study 1976-2013.
Ungprasert, P., Crowson, C. S., Carmona, E. M., & Matteson, E. L. (2018) · Sarcoidosis vasculitis and diffuse lung diseases · doi:10.36141/svdld.v35i2.6356 · Cited by 13
Self-citation
Cited by
Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis
Sève, P., Pacheco, Y., Durupt, F., Jamilloux, Y., Gerfaud-Valentin, M., Isaac, S., Boussel, L., Calender, A., Androdias, G., Valeyre, D., et al. (2021) · Cells · doi:10.3390/cells10040766 · Cited by 487
Metadata
- Authors
- Ungprasert, P., Ryu, J. H., & Matteson, E. L.
- Venue
- Mayo Clinic Proceedings: Innovations, Quality & Outcomes
- Publisher
- Elsevier BV
- Published
- 2019-09
- Volume
- 3
- Issue
- 3
- Pages
- 358-375
- ISSN
- 2542-4548 (ISSN-L)
- OpenAlex
- W2964917848
- Cited by
- 297
- References
- 93
- FWCI
- 16.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.